Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...

Aclarion shares are trading higher by 124% during Monday's session. The company announced it signed a commercial deal with ...

Aclarion (ACON) announced plans to expand Nociscan access across key markets in New York and New Jersey. The expansion plans build on previously established Nociscan sites with RadNet (RDNT) ...

Detailed price information for Aclarion Inc WT (ACONW-Q) from The Globe and Mail including charting and trades.

BROOMFIELD, Colo., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ: ACON) (NASDAQ: ...

Inc trading halted, volatility trading pauseDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

Agreement expands access to Nociscan technology for leading spine physicians and more than 3.2M people in the greater San Diego Metro ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ: ACON, ACONW), a healthcare technology company specializing in chronic low back pain diagnosis, with a current market capitalization of $7.11 million ...

Aclarion, Inc., a medical laboratories services provider, announced the approval of key proposals by its shareholders during a Special Meeting held on Tuesday. The meeting, which was initially set ...

BROOMFIELD, Colo., March 06, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company ...